Delivery Order SPE2DB20D3505-SPE2DB24FV0S8
Award Date
9/23/24
Potential Completion Date
9/24/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,190.47 firm fixed-price delivery order is for GRALISE ER 600 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of December 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,036.96 delivery order contract is for the supply of GRALISE ER 300 MG TABLET 90S, a prescription medication. The contract is a firm fixed price arrangement with a completion date of November 24, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,330.64 firm fixed-price delivery order contract is for the supply of Gralise ER 600 mg tablets. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award with the ID SPE2DX15D3015|SPE2DX24F0EZ0 was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $8,362.39 firm fixed-price delivery order is for GRALISE ER 600 MG TABLET 90S, a pharmaceutical product. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
The U.S. Defense Logistics Agency (DLA) awarded a $4,578.64 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GRALISE ER 300 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,375.08 firm fixed-price contract is for the supply of GRALISE ER 600 MG tablets. The award is not associated with a set-aside program. AmerisourceBergen, as a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Gralise ER 600 mg tablets, a pharmaceutical product, with a ceiling value of $3,288.94 and a completion date of February 23, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $4,064.50, is a delivery order for the pharmaceutical product GRALISE ER 600 MG TABLET 90S. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
The federal contract award summarized in the provided information was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,803.80 Firm Fixed Price Delivery Order contract, with a completion date of February 4, 2025, is for the supply of GRALISE ER 600 MG TABLET 90S. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,824.79, covers the delivery of Gralise ER 600 mg tablets over the period from December 6, 2024, to December 9, 2024. The contract is a firm-fixed-price arrangement, and there is no set-aside designation indicated. AmerisourceBergen holds a significant...